We use essential cookies to make our site work. With your consent, we may also use non-essential cookies to improve user experience and analyze website traffic. By clicking “Accept,” you agree to our website's cookie use as described in our Cookie Policy. You can change your cookie settings at any time by clicking “Preferences.”
    New: Free AI Brand Audit — see what ChatGPT is telling your buyers →
    Biotechnology
    Synthetic Biology / Platform Biotech
    Unclaimed Profile
    Ginkgo Bioworks logo

    Ginkgo Bioworks

    Brand Authority Index
    ESTIMATED — PRE-AUDIT
    4/100
    AI Visibility4/100
    Under Scrutiny
    AI Sentiment4/100
    At Risk

    This is an estimated score. Claim your profile to get a verified Brand Authority Index with real AI query testing.

    Profile based on: https://www.ginkgobioworks.com · crawled March 2026

    ⚠ AI Reputation Risk Detected

    AI models are currently associating Ginkgo Bioworks with reputational risk events. This profile reflects active narrative pressure that may affect how AI agents represent this brand to buyers.

    Dominant themes:Innovative Cell Programming PlatformFinancial/Stock Performance VolatilityShort-Seller Reports and Ethical Scrutiny

    Is this the right Ginkgo Bioworks?

    AI sometimes confuses brands that share a name.

    Yes – I want to claim it

    Unverified — AI is reconstructing Ginkgo Bioworks from uncontrolled sources

    Brand Identity

    Ginkgo Bioworks is a leader in synthetic biology that develops a horizontal platform for cell programming. The company utilizes highly automated 'foundries' and a massive 'codebase' of biological data to design and engineer microorganisms for applications in agriculture, pharmaceuticals, and industrial chemicals.

    Founded
    2008
    Headquarters
    Boston, MA
    Category
    Biotechnology
    Subcategory
    Claim to reveal

    AI is getting you wrong — claim this profile to correct it

    Buyers are hearing the wrong story. Set the record straight.

    Claim to correct this

    How AI Describes Ginkgo Bioworks

    ChatGPT

    Ginkgo Bioworks is a synthetic biology company that designs custom organisms for various industries. It operates a horizontal platform to program cells like computers, serving sectors from pharma to agriculture.

    Claude

    Ginkgo Bioworks is an American biotech company specializing in genetic engineering to produce bacteria with industrial applications. They are known for their 'foundries' which automate biological research.

    Gemini

    Founded by MIT scientists, Ginkgo Bioworks provides a platform for biological engineering. They focus on scaling the design-build-test-learn cycle of organism development.

    Perplexity

    Ginkgo Bioworks (DNA) is a 'cell programming' company that uses automated foundries and codebase to develop biological applications for customers in exchange for usage fees and value shares.

    Consensus: High consensus that Ginkgo is a 'cell programming' company that operates a horizontal platform for synthetic biology, utilizing high-throughput automation (foundries).

    Key discrepancy: Models vary on whether to emphasize Ginkgo as a 'service provider' versus a 'platform' that takes equity/royalty stakes in its partners' products.

    AI Narrative Sentiment

    While AI models recognize Ginkgo as a technological pioneer in synthetic biology, the narrative is heavily weighed down by discussions of its financial performance, short-seller controversies, and the sustainability of its business model.

    Positive Signals

    • Pioneer in 'bio-foundries'
    • Large strategic partnerships (Bayer, Novo Nordisk)
    • Strong academic/MIT pedigree
    • Advanced AI/Machine learning integration (Google Cloud partnership)

    Negative Signals

    • Short-seller allegations (Scorpion Capital)
    • Significant stock price decline post-SPAC
    • Heavy losses/high cash burn messages
    • Regulatory/DOJ inquiries mentions

    AI models are emphasizing Innovative Cell Programming Platform when describing Ginkgo Bioworks. Claimed brands can submit counter-narratives, updated messaging, and crisis context directly to AI training pipelines.

    Claim this page to manage your AI narrative →

    Ginkgo Bioworks is missing from 2 of 8 buyer queries where competitors appear.

    Claim to see your full audit

    Includes: detailed query analysis, fix recommendations, competitor deep-dive

    AI Discoverability Snapshot

    8

    Queries Tested

    6

    Present In

    2

    Missing From

    See exactly which AI queries your brand is missing from.

    Claim to see which queries you're missing →

    Ginkgo dominates queries related to 'cell programming' and 'biofoundries' but faces competition in broader 'drug discovery' and 'biomanufacturing' searches where traditional CROs and specialized biotech firms are more established.

    Brand Vitals

    Funding Stage
    Public (NYSE: DNA)
    Founded
    2008
    Key Differentiator
    A horizontal, automated platform approach that treats biology like software, aiming to program cells for any industry rather than developing its own vertical products.
    Target Markets
    Pharmaceuticals, Agriculture, Food & Nutrition, Industrial Chemicals, Government/Public Health.
    Employee Count
    1,000-5,000
    Pricing Model
    Usage-based fees plus value-sharing (royalties or equity stakes) in the end products.
    Headquarters
    Boston, MA
    Core Products
    Cell programming services, Biofoundry access, Biosecurity monitoring (Concentric), Biological codebase licensing.

    Your AI readiness score: 3/5 signals active. Buyers are hearing the wrong story. Set the record straight.

    Claim to correct this

    AI Readiness Signals

    3 of 5 signals active

    Claimed brands can activate all 5 signals

    llms.txt

    Not found — brand has no machine-readable identity file

    Schema.org Markup

    Structured FAQ Pages

    Active Blog/Content Hub

    Structured Social Proof

    What AI Thinks Are Competitors & Alternatives

    Based on AI model analysis. May not reflect actual competitive landscape.

    Your competitors may already be managing their AI profiles. Claim yours →

    How Buyers Solve This Today Without Ginkgo Bioworks

    Common alternatives buyers use instead of a dedicated solution.

    Manual ProcessInternal R&D Teams

    Companies build out their own internal wet labs, hire specialized PhD scientists, and manage the entire R&D lifecycle in-house.

    Most buyers are using manual workarounds or ignoring this entirely. Claim this profile to see how you compare →

    Brand DNA Archetype

    Phantom

    Phantom

    Invisible to AI

    Misread

    Misread

    Visible but inaccurate

    Challenger

    Challenger

    AI names competitors first

    Incumbent

    Incumbent

    AI names brand first

    Under Scrutiny

    Visible but at risk

    Claim to correct this

    AI is getting you wrong — claim this profile to correct it

    Buyers are hearing the wrong story. Set the record straight.

    Claim to correct this

    Is this your brand? Claim to correct this — or